Skip to main content

Ulta Beauty, Inc.

For the period ended Nov 1, 2025. Filed Dec 4, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Nov 1, 2025 · Filed Dec 4, 2025

ULTA$664.41-0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

​​​​​​​
​ · ​ · 39 Weeks Ended
​ · ​ · November 1, · ​ · November 2,
(In thousands)20252024
Operating activities​​​​​​
Net income​$796,802​$807,848
Adjustments to reconcile net income to net cash provided by operating activities:​​​​​
Depreciation and amortization​​218,985​​197,075
Non-cash lease expense​​260,632​​235,950
Deferred income taxes​​(1,613)​​5,808
Stock-based compensation expense​​30,324​​27,691
Loss on disposal of property and equipment​​7,398​​7,280
Equity net loss of affiliate​​2,210​​—
Change in operating assets and liabilities:​​​​​​
Receivables​​(13,138)​​(5,682)
Merchandise inventories​​(702,678)​​(623,050)
Prepaid expenses and other current assets​​(14,088)​​(19,916)
Income taxes​​(67,994)​​(69,818)
Accounts payable​​123,911​​54,210
Accrued liabilities​​6,567​​(45,777)
Deferred revenue​​(41,642)​​(31,551)
Operating lease liabilities​​(261,864)​​(250,267)
Other assets and liabilities​​(21,628)​​12,240
Net cash provided by operating activities​​322,184​​302,041
​​​​​​​
Investing activities​​​​​​
Capital expenditures​​(243,262)​​(300,536)
Acquisitions, net of cash acquired​​(386,793)​​—
Other investments​​(25,445)​​(6,108)
Net cash used in investing activities​​(655,500)​​(306,644)
​​​​​​​
Financing activities​​​​​​
Borrowings from short-term debt​​1,641,844​​199,700
Payments on short-term debt​​(1,118,683)​​—
Repurchase of common shares​​(703,960)​​(765,384)
Stock options exercised​​30,103​​9,200
Purchase of treasury shares​​(13,505)​​(23,566)
Debt issuance costs​​(763)​​(4,159)
Net cash used in financing activities​​(164,964)​​(584,209)
​​​​​​​
Net decrease in cash and cash equivalents​​(498,280)​​(588,812)
Cash and cash equivalents at beginning of period​​703,201​​766,594
Cash and cash equivalents at end of period​$204,921​$177,782
​​​​​​​
Supplemental information​​​​​​
Income taxes paid, net of refunds$326,360​$316,790
Non-cash investing and financing activities:​​​​​​
Non-cash capital expenditures​​88,468​​47,431
Repurchase of common shares in accrued liabilities​​3,999​​—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.